The inhibition of Citrobacter freundii cephalosporinase activity by moxalactam is shown to be due to the formation of a transiently stable covalent complex, probably acyl enzyme. The covalent complex formed was identified by coelution of [14C]moxalactam with the enzyme by using Sephadex G-25 gel filtration in the presence of 5.7 M guanidine hydrochloride and by analytical isoelectric focusing. Both the side-chain carboxyl group and the 7a-methoxy group of maxalactam were necessary to stabilize the complex. Moxalactam is racemic with respect to the a carbon of the 7jp-acylamino side chain, and the complex with the R epimer (half-life, 4.6 min) decomposed much more rapidly than that formed with the S epimer (half-life, 130 min). For other P-lactam antibiotics that were stable to ,-lactamase, the half-lives of enzyme-antibiotic complexes were less than 4 min.
, is stable against both cephalosporinases and penicillinases and offers improved antibacterial activities. The remarkable structural elements of moxalactam leading to 13 -lactamase stability are the 7a-methoxy group, which stabilizes it against penicillinases and against the cephalosporinase of Proteus vulgaris, and the a-carboxyl group of the 7p-acylamino side chain (side-chain carboxyl group), which confers a high affinity for cephalosporinases of bacteria other than P. vulgaris and in turn leads to enzyme inhibition (13, 25) . To understand the stability of moxalactam at the molecular level, we examined its interaction with the cephalosporinase of Citrobacter freundii, keeping the two substituents described above in mind. We found that moxalactam inhibited the enzyme by forming a transiently stable covalent complex with it, thereby gaining stability against the enzyme, and that both the substituents and the configuration around the asymmetric carbon at the a position of the 7-acylamino side chain affected the stability of the complex. We also compared the half-lives of the moxalactam complexes with those of other ,-lactam antibiotics of current interest.
MATERIALS AND METHODS

I8-Lactam antibiotics.
[14C]moxalactam (12.2 mCi/mmol), which contained about equimolar amounts of R and S epimers (8) , compound 1 (the demethoxy derivative of moxalactam), and compound 2 (the side-chain decarboxyl derivative of moxalactam), were synthesized, and asparenomycin A was isolated from a fermentation broth of Streptomyces sp. (20) Purification of cephalosporinase. C. freundii SR19, which produces cephalosporinase constitutively, was grown without shaking overnight at 37°C in nutrient phosphate broth (Nissui, Tokyo, Japan). Cells (27 g [wet weight]) were washed in 1 liter of 0.85% NaCl, suspended in an appropriate volume of 0.01 M Na2HPO4-KH2PO4 (pH 6.6), and then subjected to ultrasonic disintegration for 5 min in an ice bath with a Sonifier 350 (Branson Sonic Power Co., Danbury, Conn.). Cell debris was removed by centrifugation at 33,000 x g for 30 min at 4°C, and the supernatant was dialyzed against the phosphate buffer described above (pH 6.6).
The dialyzed supernatant (75 ml) was applied to a carboxymethyl Sephadex C-50 column (2.6 by 34 cm) equilibrated with 0.01 M phosphate buffer (pH 6.6). The column was washed with 410 ml of the same buffer, and the cephalosporinase was eluted with a linear gradient constructed from 500 ml of 0.01 M phosphate buffer (pH 6.6) and 500 ml of 0.5 M phosphate buffer (pH 6.2). Pooled active fractions were dialyzed against distilled water and concentrated by lyophilization.
The concentrated enzyme solution (2 ml) was applied to and eluted from a Sephadex G-75 column (2.6 by 95 cm) equilibrated with 0.1 M potassium phosphate buffer (pH 7.0). A pooled active fraction containing 24 mg of enzyme protein was stored at -78°C until use.
The overall recovery of enzyme activity was 65%. The purified enzyme was more than 95% homogeneous based on the results of both polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and analytical isoelectric focusing on a thin layer of polyacrylamide gel.
Assay of j8-lactamase. P-Lactamase activity was determined by spectrophotometric assay (14) with a Hitachi model 200-20 spectrophotometer into which water at 30°C was circulated.
The maximum hydrolysis rate (Vmax) and Michaelis constant (Kin) of the P-lactam compounds were calculated from Lineweaver-Burk plots (11 (ii) Other I-lactam compounds. The enzyme (5 ,uM) was incubated at 30°C for 1 min with P-lactam compound (5 or 10
,uM) in the buffer. The 10-,lI portion was then diluted with 20 ml of the buffer, and 0.2 ml of the diluted solution was immediately added to 2 ml of cephaloridine (110 ,uM) in a cuvette for spectrophotometric analysis at 30°C. The time course of the change in optical density at 260 nm was recorded with a Hitachi recorder. The instantaneous hydrolysis rates of cephaloridine were obtained from the tangential slope of the time course curve at the corresponding times.
Both of these methods (i and ii) indicated similar half-lives for the complex formed with the R epimer of moxalactam. The concentration of intact ,-lactam after dilution was always low enough so that its effect as an inhibitor was negligible.
Analytical isoelectric focusing. Analytical isoelectric focusing on a thin layer of polyacrylamide gel was performed with an LKB Multiphor apparatus according to the instructions of the manufacturer. Samples were run on an LKB Ampholine PAG plate (pH 3.5 to 9.5) for 2 h at a constant level of power. Proteins were stained with Coomassie brilliant blue R-250.
RESULTS
Kinetic properties of C. freundii cephalosporinase and its inhibition by moxalactam. The P-lactamase of the C. freundii strain used in this study was more active against cephalosporins, such as cephalothin and cephaloridine, than against ampicillin and was inhibited by an excess of moxalactam (Table 1) , as were the cephalosporinases of other bacterial species (10, 13, 16, 26) . Even at lower molar ratios of moxalactam to the enzyme (1.0 to 2.0), the antibiotic inhibited enzymatic activity by 90 to 95% until the activity could recover (Fig. 2) . When the molar ratio of antibiotic to enzyme was increased, a longer incubation period was required before the recovery of enzyme activity began.
Specific covalent binding of moxalactam to the cephalosporinase. After incubation of the cephalosporinase with ['4C]moxalactam at a molar ratio of 10 (antibiotic to enzyme), the enzyme-antibiotic mixture was eluted from a Sephadex G-25 column in the presence of 5.7 M guanidine hydrochloride. A small amount of radioactive material was coeluted with the denatured enzyme (peak I in Fig. 3 ; peak II in Fig. 3 given for each curve. At the indicated times, 10-Rl portions were taken, and after appropriate dilution, the P-lactamhase activities were determined with 100 ,uM of cephaloridine as the substrate.
lished data), it is supposed to be completely denatured and to become a random coil in 5.7 M guanidine hydrochloride (21) . Thus, the moxalactam of peak I evidently formned a covalent complex with the enzyme, and this complex was stable for at least 4 h at room temperature in the presence of 5.7 M guanidine hydrochloride. The binding of [14C]moxalactam to the enzyme was inhibited when the enzyme had been denatured previously with guanidine hydrochloride (Fig. 3) . This binding was also blocked by preincubation of the enzyme with cold moxalactam or asparenomycin A, a carbapenem which inhibits the cephalosporinase (12; data not shown). Incubation of moxalactam with an equimolar concentration of the enzyme led to the disappearance of UV absorbance of the ,-lactam ring (Fig. 4) , indicating that when moxalactam was specifically bound to the enzyme, its P-lactam ring was opened by the enzyme action.
The complexes were also detected by analytical isoelectric focusing on a thin layer of polyacrylamide gel (Fig. 5) . Two new bands (a major and a minor band) appeared in. a more acidic range, demonstrating the formation of two kinds of complexes. The native enzyme band exhibited tailing, which showed the regeneration of native enzyme molecules from the complex during the isoelectric focusing.
Decomposition of the enzyme-moxalactam complex. Although the covalent complex was stable in the presence of 5.7 M guanidine hydrochloride, it decomposed when the enzyme was intact (Fig. 2) moxalactam at 300C and at time zero was diluted with the buffer to remove the inhibition by free moxalactam. The incubation was continued, and the rate of recovery of enzyme activity was monitored. When the enzyme was preincubated with moxalactam for 1 min, recovery of activity was biphasic, with an initial rapid phase followed by a slow phase (Fig. 6A) . Decomposition of the complex in the slow phase followed first-order kinetics, and the half-life was 130 min. Extrapolation of the slow-phase slope to time zero showed that about 50% of the complex at time zero had a half-life of 130 min. When the preincubation time before dilution was 50 min, the rapidly decaying complex was almost lost (Fig. 6B) . Because moxalactam contains an asymmetric carbon at the a position of the 7-acylamino moiety, moxalactam preparations usually contain approximately equimolar amounts of R and S epimers (9) . The decomposition of complex formed with the R epimer, as measured in a preparation containing 97% R epimer, was monophasic and followed first-order kinetics with a half-life of 4.6 min (Fig. 7) . Thus, the rapid and slow phases (Fig. 6A) evidently resulted from the decay of complexes with R and S epimers, respectively. The observation that at time zero about 50% of the complex was the slowly decaying type agreed with the fact that moxalactam preparations are composed of almost equimolar amounts of R and S epimers.
Comparison of half-lives among enzyme-antibiotic complexes formed with various ,l-lactam compounds. The halflives of complexes formed with various ,3-lactam compounds known to be resistant to hydrolysis by 1-lactamases are shown in Table 1 . Though carbenicillin has an asymmetric carbon, its decomposition curve was not biphasic but monophasic (as in Fig. 7) . Extrapolation of the curve indicated less than 50% inhibition at time zero. The half-life of complexes with one of the two epimers of carbenicillin was probably too short to measure, and Table 1 shows the value for the complex with the longer half-life. Of the P-lactam compounds listed in Table 1 , the S epimer of moxalactam formed the most stable complex, followed by the moxalactam R epimer, carbenicillin, and cefotaxime. Complexes with compounds other than the S epimer, however, exhibited half-lives of only 3 to 4 min. Complexes of the other compounds were too labile to allow measurement of their half-lives.
DISCUSSION
Moxalactam reportedly inhibits cephalosporinases of many gram-negative bacteria (10, 13, 16, 26) . In this study with the cephalosporinase of C. freundii, moxalactam was shown to inhibit the enzyme by forming a transiently stable covalent complex. The formation of the complex prevented the enzyme from attacking other moxalactam molecules. Bush et al. have reported the formation of moxalactam complexes with the cephalosporinase ofEnterobacter cloacae (2) . Thus, these complexes seem to form with the cephalosporinases of other bacterial species which moxalactam inhibits.
P-Lactamase inactivators such as clavulanic acid, 613-bromopenicillanic acid, penicillanic acid sulfone, and carbapenems have been shown to irreversibly inactivate ,B-lactamases (3, 4, 6, 12, 15 (Table 1) , the half-life of its complex with the enzyme was less than 2 min. Compound 2 was hydrolyzed at a rate that was 29% that of cephalothin. In contrast, the moxalactam complex had a longer lifetime. Cooperation of the side-chain carboxyl group with the 7a-methoxy group was critical for the stability of the complex. Another factor affecting the stability was the configuration around the a carbon of the 7-acylamino side chain. The S configuration stabilized the complex much more effectively than did the R configuration.
The R epimer of moxalactam has a stronger antibacterial activity against many bacterial strains than does the S epimer (23) . However, the R epimer is less active against some cephalosporinase-producing strains (T. Yoshida, Y. Kameda, and Y. Kimura, unpublished data), probably because of its instability to the enzyme. In a preparation of moxalactam containing equimolar amounts of R and S epimer, the R epimer would be protected to some extent from cephalosporinase by the S epimer, and both epimers are likely to act synergistically against cephalosporinase-producing strains.
The isoelectric focusing pattern showed that two kinds of complexes were formed with moxalactam. The major and the minor bands were probably not derived from the S and R epimers, respectively, because the enzyme incubated with the R epimer also showed two very faint bands at the same position (presumably due to a minute amount of the S epimer in the preparation) and because the complex formed with the R epimer was too labile to be detected by isoelectric focusing. The difference between the two bands is unclear.
There have been several studies concerning the involvement of P-lactamase in bacterial resistance to P-lactamasestable P-lactam antibiotics (19, 22, 24) , and nonhydrolytic mechanisms such as the trapping of the compound by 13-lactamase or the presence of a penetration barrier determined by P-lactamase have been proposed (18) . Although hydrolysis could not be detected by conventional methods, all of the P-lactam compounds listed in Table 1 were hydrolyzed, and large differences in stability were found in terms of the half-life of the enzyme-antibiotic complex. Thus, any discussion of the participation of P-lactamase in the resistance to so-called nonhydrolyzable P-lactam antibiotics would require more precise assessments of such factors as the decomposition rate of the complex.
